119 related articles for article (PubMed ID: 7505049)
21. [Hepatocellular carcinoma (HCC): the long-term response to tamoxifen. A clinical case report and review of the literature].
Recchia F; Passalacqua G; Rodorigo C; Belli L; Morgante A; Rabitti G
Minerva Med; 1989 Dec; 80(12):1363-6. PubMed ID: 2560153
[TBL] [Abstract][Full Text] [Related]
22. Adriamycin and cisplatin for hepatoblastoma.
Quinn JJ; Altman AJ; Robinson HT; Cooke RW; Hight DW; Foster JH
Cancer; 1985 Oct; 56(8):1926-9. PubMed ID: 2411381
[TBL] [Abstract][Full Text] [Related]
23. Systemic combined chemotherapy with low dose of 5-fluorouracil, cisplatin, and interferon-alpha for advanced hepatocellular carcinoma: a pilot study.
Komorizono Y; Kohara K; Oketani M; Maeda M; Shibathou T; Shigenobu S; Hiramine Y; Yamasaki N; Arima T; Kazuaki I; Arima T
Dig Dis Sci; 2003 May; 48(5):877-81. PubMed ID: 12772783
[TBL] [Abstract][Full Text] [Related]
24. Fibrolamellar hepatocellular carcinoma in an infant and literature review.
Cruz O; Laguna A; Vancells M; Krauel L; Medina M; Mora J
J Pediatr Hematol Oncol; 2008 Dec; 30(12):968-71. PubMed ID: 19131794
[TBL] [Abstract][Full Text] [Related]
25. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
Ortega JA; Krailo MD; Haas JE; King DR; Ablin AR; Quinn JJ; Feusner J; Campbell JR; Lloyd DA; Cherlow J
J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
[TBL] [Abstract][Full Text] [Related]
26. [A case of hepatocellular carcinoma in an elderly patient that improved upon combination therapy of Lentinan and Tegafur].
Takahashi T; Hori Y; Isogawa S; Saho M; Yoshida H; Yokoyama K; Watanabe M; Nakagawa S
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1517-9. PubMed ID: 1697155
[TBL] [Abstract][Full Text] [Related]
27. Complete disappearance of unresectable hepatoblastoma by continuous infusion therapy through hepatic artery.
Yokomori K; Hori T; Asoh S; Tuji A; Takemura T
J Pediatr Surg; 1991 Jul; 26(7):844-6. PubMed ID: 1654408
[TBL] [Abstract][Full Text] [Related]
28. Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.
Shah S; Gupta S; Shet T; Maheshwari A; Wuntkal R; Mohandas KM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):306-7. PubMed ID: 15908336
[TBL] [Abstract][Full Text] [Related]
29. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
30. [Hepatic artery infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II in the treatment of malignant liver tumors].
Morita S; Matsumoto S; Odani R
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):689-95. PubMed ID: 2451473
[TBL] [Abstract][Full Text] [Related]
31. [A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
Enomoto H; Ishii A; Imanishi H; Saito M; Tanaka H; Iwata Y; Sakai Y; Iwai T; Yoh K; Takashima T; Yoshikawa S; Aizawa N; Yamamoto T; Ikeda N; Shimomura S; Iijima H; Hirota S; Nishiguchi S
Gan To Kagaku Ryoho; 2010 May; 37(5):919-22. PubMed ID: 20495329
[TBL] [Abstract][Full Text] [Related]
32. [A report of two cases--two patients of the extremely advanced hepatocellular carcinoma have responded completely for a long time after a combination therapy consisting of arterial chemotherapy and injection of interferon-alpha].
Iijima S; Kikkawa N; Kurokawa E; Yamamoto H; Kato T; Tsujie M; Ohshima S; Hayashi T; Naoi Y; Hatanaka T; Danno M; Sakon M; Nagano H; Dono K; Nakamori S; Umeshita K; Monden M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1669-72. PubMed ID: 14619490
[TBL] [Abstract][Full Text] [Related]
33. Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Miyamoto A; Umeshita K; Sakon M; Nagano H; Eguchi H; Kishimoto S; Dono K; Nakamori S; Gotoh M; Monden M
J Gastroenterol Hepatol; 2000 Dec; 15(12):1447-51. PubMed ID: 11197059
[TBL] [Abstract][Full Text] [Related]
34. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
[TBL] [Abstract][Full Text] [Related]
35. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
Leung TW; Tang AM; Zee B; Yu SC; Lai PB; Lau WY; Johnson PJ
Cancer; 2002 Jan; 94(2):421-7. PubMed ID: 11905412
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of interferon alpha and 5-fluorouracil in hepatocellular carcinoma.
Mughal TI; Koriech OM
Acta Oncol; 1996; 35(2):248. PubMed ID: 8639324
[No Abstract] [Full Text] [Related]
37. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
[TBL] [Abstract][Full Text] [Related]
38. [Investigating the alpha-1-fetoprotein in the blood stream of patients with primary hepatocellular carcinoma in the course of chemotherapy (author's transl)].
Zizkovský V; Kordac V; Masek Z; Stĕpán J; Korcáková J; Blahníková L
Cesk Gastroenterol Vyz; 1980 Oct; 34(7):465-73. PubMed ID: 6160917
[No Abstract] [Full Text] [Related]
39. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
40. Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion.
Imura S; Ikemoto T; Morine Y; Fujii M; Miyake H; Tashiro S; Shimada M
Hepatogastroenterology; 2008; 55(82-83):615-20. PubMed ID: 18613419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
